Study identifies new potential target in glioblastoma
DNA-binding protein inhibitor ID1 helps maintain cancer stem cells in brain, breast and skin cancer, making tumours resistant to chemotherapy, research suggests
Source: St. Michael's Hospital News and Media - Category: Hospital Management Tags: Hospital News Source Type: news
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Chemotherapy | Hospital Management | Hospitals | Neurology | Skin | Skin Cancer | Stem Cell Therapy | Stem Cells | Study